Dr. Timothy J. Panella
Claim this profileUniversity of Tennessee - Knoxville
Studies Breast Cancer
Studies Cancer
9 reported clinical trials
19 drugs studied
Area of expertise
1Breast Cancer
HER2 positive
ER positive
PR negative
2Cancer
HER2 positive
Stage III
ER positive
Affiliated Hospitals
Clinical Trials Timothy J. Panella is currently running
T-DM1 + Tucatinib
for Breast Cancer
This phase III trial studies how well trastuzumab emtansine (T-DM1) and tucatinib work in preventing breast cancer from coming back (relapsing) in patients with high risk, HER2 positive breast cancer. T-DM1 is a monoclonal antibody, called trastuzumab, linked to a chemotherapy drug, called DM1. Trastuzumab is a form of targeted therapy because it attaches to specific molecules (receptors) on the surface of cancer cells, known as HER2 receptors, and delivers DM1 to kill them. Tucatinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving T-DM1 and tucatinib may work better in preventing breast cancer from relapsing in patients with HER2 positive breast cancer compared to T-DM1 alone.
Recruiting1 award Phase 313 criteria
Imlunestrant
for Early Breast Cancer
This trial is testing a new medication called imlunestrant to see if it works better than standard hormone treatments for certain breast cancer patients. The study focuses on patients with early-stage breast cancer that is estrogen receptor positive and HER2 negative, who have already been on hormone therapy for a period of time and are at high risk of their cancer returning. Imlunestrant works by blocking estrogen from helping cancer cells grow.
Recruiting2 awards Phase 36 criteria
More about Timothy J. Panella
Clinical Trial Related3 years of experience running clinical trials · Led 9 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Timothy J. Panella has experience with
- Pembrolizumab
- Abemaciclib
- PDS0101
- Therapeutic Conventional Surgery
- Avelumab
- Cetuximab
Breakdown of trials Timothy J. Panella has run
Breast Cancer
Cancer
Squamous Cell Carcinoma
Skin Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Timothy J. Panella specialize in?
Timothy J. Panella focuses on Breast Cancer and Cancer. In particular, much of their work with Breast Cancer has involved HER2 positive patients, or patients who are ER positive.
Is Timothy J. Panella currently recruiting for clinical trials?
Yes, Timothy J. Panella is currently recruiting for 2 clinical trials in Knoxville Tennessee. If you're interested in participating, you should apply.
Are there any treatments that Timothy J. Panella has studied deeply?
Yes, Timothy J. Panella has studied treatments such as Pembrolizumab, Abemaciclib, PDS0101.
What is the best way to schedule an appointment with Timothy J. Panella?
Apply for one of the trials that Timothy J. Panella is conducting.
What is the office address of Timothy J. Panella?
The office of Timothy J. Panella is located at: University of Tennessee - Knoxville, Knoxville, Tennessee 37920 United States. This is the address for their practice at the University of Tennessee - Knoxville.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.